文献速递临床试验与 GCP真实世界研究与卫生经济

综合个性化辅助器具方案降低糖尿病足溃疡复发风险(DIASSIST):多中心随机对照试验研究方案

An integrated personalized assistive devices approach to reduce the risk of foot ulcer recurrence in diabetes (DIASSIST): study protocol for a multicenter randomized controlled trial.
PubMed 文献 · Trials · 2023-10-12

本研究为平行组多中心随机对照试验,拟纳入126例1型或2型糖尿病、存在周围神经病变导致保护性感觉丧失、过去4年内足底溃疡已愈合且拥有定制鞋具的成人患者,随机分为增强治疗组与常规治疗组,随访12个月,评估足溃疡复发、鞋具依从性和成本效用三个主要结局。

要点

  • 增强治疗在常规治疗基础上增加压力优化定制鞋具、室内用压力优化定制鞋具、居家每日足部温度监测和结构化教育。
  • 研究主要结局为足溃疡复发、鞋具依从性和成本效用,分别对应临床、患者相关和健康经济结局。
  • 研究纳入标准包括过去4年内足底溃疡已愈合且拥有任何类型定制鞋具的高危糖尿病患者。

核心结论

  • 作者假设结合多种鞋具、自我管理和教育干预并匹配个体需求的多模式治疗方法可降低溃疡复发风险并具有有益的成本效用。
  • 作者认为这是首个将多种溃疡预防干预整合为个性化先进治疗方案并在高危糖尿病患者中通过随机对照试验评估其联合疗效的研究。

研究设计与样本

  • 平行组多中心随机对照试验,拟纳入126例成人1型或2型糖尿病患者,随机分为增强治疗组或常规治疗组,随访12个月。
  • 纳入标准为存在周围神经病变导致保护性感觉丧失、过去4年内足底溃疡已愈合且拥有任何类型定制鞋具。

主要发现

  • 研究评估足溃疡复发、鞋具依从性和成本效用三个主要结局,分别对应主要临床、患者相关和健康经济结局。
  • 评估包括赤足和鞋内足底压力测量、生活质量与成本及疾病和自我护理知识问卷、体力活动和鞋具使用监测以及足溃疡结局的临床监测。

关键数值与推荐

  • 增强治疗包括常规治疗以及个性化治疗方法,含压力优化定制鞋具、室内用压力优化定制鞋具、居家每日足部温度监测和结构化教育,结构化教育包括动机性访谈以及关于依从性和自我护理的个性化反馈。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preventing foot ulcers in people with diabetes can increase quality of life and reduce costs. Despite the availability of various interventions to prevent foot ulcers, recurrence rates remain high. We hypothesize that a multimodal treatment approach incorporating various footwear, self-management, and education interventions that matches an individual person's needs can reduce the risk of ulcer recurrence with beneficial cost-utility. The aim of this study is to assess the effect on foot ulcer recurrence, footwear adherence, and cost-utility of an integrated personalized assistive devices approach in high-risk people with diabetes. METHODS: In a parallel-group multicenter randomized controlled trial, 126 adult participants with diabetes mellitus type 1 or 2, loss of protective sensation based on the presence of peripheral neuropathy, a healed plantar foot ulcer in the preceding 4 years, and possession of any type of custom-made footwear will be included. Participants will be randomly assigned to either enhanced therapy or usual care. Enhanced therapy consists of usual care and additionally a personalized treatment approach including pressure-optimized custom-made footwear, pressure-optimized custom-made footwear for indoor use, at-home daily foot temperature monitoring, and structured education, which includes motivational interviewing and personalized feedback on adherence and self-care. Participants will be followed for 12 months. Assessments include barefoot and in-shoe plantar pressure measurements; questionnaires concerning quality of life, costs, disease, and self-care knowledge; physical activity and footwear use monitoring; and clinical monitoring for foot ulcer outcomes. The study is powered for 3 primary outcomes: foot ulcer recurrence, footwear adherence, and cost-utility, the primary clinical, patient-related, and health-economic outcome respectively. DISCUSSION: This is the first study to integrate multiple interventions for ulcer prevention into a personalized state-of-the-art treatment approach and assess their combined efficacy in a randomized controlled trial in people with diabetes at high ulcer risk. Proven effectiveness, usability, and cost-utility will facilitate implementation in healthcare, improve the quality of life of high-risk people with diabetes, and reduce treatment costs. TRIAL REGISTRATION: ClinicalTrials.gov NCT05236660. Registered on 11 February 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Vossen LE, van Netten JJ, Bakker CD, et al. An integrated personalized assistive devices approach to reduce the risk of foot ulcer recurrence in diabetes (DIASSIST): study protocol for a multicenter randomized controlled trial. Trials. 2023. PMID: 37828618. doi:10.1186/s13063-023-07635-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。